China Non-Specific Cancer Immunotherapy Drug Market Research Report 2017

January 2017 | 98 pages | ID: CD01F4699A9EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Non-Specific Cancer Immunotherapy Drug

Revenue, means the sales value of Non-Specific Cancer Immunotherapy Drug

This report studies Non-Specific Cancer Immunotherapy Drug in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering

• Amgen
• Roche
• Bristol Myers Squibb
• Dendreon (Valeant)
• Novartis
• Seattle Genetics

Market Segment by Regions (provinces), covering

• South China
• East China
• Southwest China
• Northeast China
• North China
• Central China
• Northwest China

Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Tablet
• Injection

Split by Application, this report focuses on consumption, market share and growth rate of Non-Specific Cancer Immunotherapy Drug in each application, can be divided into

• Leukemia Treatment
• Colorectal Cancer Treatment
• Other Cancer Treatment

Contents

China Non-Specific Cancer Immunotherapy Drug Market Research Report 2017

1 NON-SPECIFIC CANCER IMMUNOTHERAPY DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Non-Specific Cancer Immunotherapy Drug
1.2 Non-Specific Cancer Immunotherapy Drug Segment by Type
  1.2.1 China Production Market Share of Non-Specific Cancer Immunotherapy Drug Type in 2015
  1.2.2 Tablet
  1.2.3 Injection
1.3 Applications of Non-Specific Cancer Immunotherapy Drug
  1.3.1 Non-Specific Cancer Immunotherapy Drug Consumption Market Share by Application in 2015
  1.3.2 Leukemia Treatment
  1.3.3 Colorectal Cancer Treatment
  1.3.4 Other Cancer Treatment
1.4 China Market Size (Value) of Non-Specific Cancer Immunotherapy Drug (2011-2021)
1.5 China Non-Specific Cancer Immunotherapy Drug Status and Outlook
1.6 Government Policies

2 CHINA NON-SPECIFIC CANCER IMMUNOTHERAPY DRUG MARKET COMPETITION BY MANUFACTURERS

2.1 China Non-Specific Cancer Immunotherapy Drug Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Non-Specific Cancer Immunotherapy Drug Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Non-Specific Cancer Immunotherapy Drug Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Non-Specific Cancer Immunotherapy Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Non-Specific Cancer Immunotherapy Drug Market Competitive Situation and Trends
  2.5.1 Non-Specific Cancer Immunotherapy Drug Market Concentration Rate
  2.5.2 Non-Specific Cancer Immunotherapy Drug Market Share of Top 3 and Top 5 Manufacturers

3 CHINA NON-SPECIFIC CANCER IMMUNOTHERAPY DRUG MANUFACTURERS PROFILES/ANALYSIS

3.1 Amgen
  3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.1.2 Non-Specific Cancer Immunotherapy Drug Product Type, Application and Specification
    3.1.2.1 Tablet
    3.1.2.2 Injection
  3.1.3 Amgen Non-Specific Cancer Immunotherapy Drug Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.1.4 Main Business/Business Overview
3.2 Roche
  3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.2.2 Non-Specific Cancer Immunotherapy Drug Product Type, Application and Specification
    3.2.2.1 Tablet
    3.2.2.2 Injection
  3.2.3 Roche 98 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.2.4 Main Business/Business Overview
3.3 Bristol Myers Squibb
  3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.3.2 Non-Specific Cancer Immunotherapy Drug Product Type, Application and Specification
    3.3.2.1 Tablet
    3.3.2.2 Injection
  3.3.3 Bristol Myers Squibb 108 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.3.4 Main Business/Business Overview
3.4 Dendreon (Valeant)
  3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.4.2 Non-Specific Cancer Immunotherapy Drug Product Type, Application and Specification
    3.4.2.1 Tablet
    3.4.2.2 Injection
  3.4.3 Dendreon (Valeant) Jan Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.4.4 Main Business/Business Overview
3.5 Novartis
  3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.5.2 Non-Specific Cancer Immunotherapy Drug Product Type, Application and Specification
    3.5.2.1 Tablet
    3.5.2.2 Injection
  3.5.3 Novartis Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.5.4 Main Business/Business Overview
3.6 Seattle Genetics
  3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.6.2 Non-Specific Cancer Immunotherapy Drug Product Type, Application and Specification
    3.6.2.1 Tablet
    3.6.2.2 Injection
  3.6.3 Seattle Genetics Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.6.4 Main Business/Business Overview

4 CHINA NON-SPECIFIC CANCER IMMUNOTHERAPY DRUG CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2011-2016)

4.1 China Non-Specific Cancer Immunotherapy Drug Capacity, Production and Growth (2011-2016)
4.2 China Non-Specific Cancer Immunotherapy Drug Revenue and Growth (2011-2016)
4.3 China Non-Specific Cancer Immunotherapy Drug Production, Consumption, Export and Import (2011-2016)

5 CHINA NON-SPECIFIC CANCER IMMUNOTHERAPY DRUG PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 China Non-Specific Cancer Immunotherapy Drug Production and Market Share by Type (2011-2016)
5.2 China Non-Specific Cancer Immunotherapy Drug Revenue and Market Share by Type (2011-2016)
5.3 China Non-Specific Cancer Immunotherapy Drug Price by Type (2011-2016)
5.4 China Non-Specific Cancer Immunotherapy Drug Production Growth by Type (2011-2016)

6 CHINA NON-SPECIFIC CANCER IMMUNOTHERAPY DRUG MARKET ANALYSIS BY APPLICATION

6.1 China Non-Specific Cancer Immunotherapy Drug Consumption and Market Share by Application (2011-2016)
6.2 China Non-Specific Cancer Immunotherapy Drug Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Application
  6.3.2 Emerging Markets/Countries

7 CHINANON-SPECIFIC CANCER IMMUNOTHERAPY DRUG MARKET ANALYSIS BY REGIONS (PROVINCES)

7.1 China Non-Specific Cancer Immunotherapy Drug Production, Production Value and Price by Regions (Provinces)(2011-2016)
  7.1.1 China Non-Specific Cancer Immunotherapy Drug Production and Market Share by Regions (Provinces)(2011-2016)
  7.1.2 China Non-Specific Cancer Immunotherapy Drug Production Value and Market Share by Regions (Provinces)(2011-2016)
  7.1.3 China Non-Specific Cancer Immunotherapy Drug Sales Price by Regions (Provinces)(2011-2016)
7.2 China Non-Specific Cancer Immunotherapy Drug Consumption by Regions (Provinces)(2011-2016)
7.3 China Non-Specific Cancer Immunotherapy Drug Production, Consumption, Export and Import (2011-2016)

8 NON-SPECIFIC CANCER IMMUNOTHERAPY DRUG MANUFACTURING COST ANALYSIS

8.1 Non-Specific Cancer Immunotherapy Drug Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Non-Specific Cancer Immunotherapy Drug

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Non-Specific Cancer Immunotherapy Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Non-Specific Cancer Immunotherapy Drug Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 CHINA NON-SPECIFIC CANCER IMMUNOTHERAPY DRUG MARKET FORECAST (2016-2021)

12.1 China Non-Specific Cancer Immunotherapy Drug Capacity, Production, Revenue Forecast (2016-2021)
12.2 China Non-Specific Cancer Immunotherapy Drug Production, Import, Export and Consumption Forecast (2016-2021)
12.3 China Non-Specific Cancer Immunotherapy Drug Production Forecast by Type (2016-2021)
12.4 China Non-Specific Cancer Immunotherapy Drug Consumption Forecast by Application (2016-2021)
12.5 China Non-Specific Cancer Immunotherapy Drug Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)
  12.5.1 China Non-Specific Cancer Immunotherapy Drug Production Forecast by Regions (Provinces)(2016-2021)
  12.5.2 China Non-Specific Cancer Immunotherapy Drug Consumption Forecast by Regions (Provinces)(2016-2021)
  12.5.3 China Non-Specific Cancer Immunotherapy Drug Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)
12.6 Non-Specific Cancer Immunotherapy Drug Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Non-Specific Cancer Immunotherapy Drug
Figure China Production Market Share of Non-Specific Cancer Immunotherapy Drug by Type in 2015
Figure Product Picture of Tablet
Table Major Manufacturers of Tablet
Figure Product Picture of Injection
Table Major Manufacturers of Injection
Table Non-Specific Cancer Immunotherapy Drug Consumption Market Share by Application in 2015
Figure Leukemia Treatment Examples
Figure Colorectal Cancer Treatment Examples
Figure Other Cancer Treatment Examples
Figure China Non-Specific Cancer Immunotherapy Drug Revenue (Million USD) and Growth Rate (2011-2021)
Table China Non-Specific Cancer Immunotherapy Drug Capacity of Key Manufacturers (2015 and 2016)
Table China Non-Specific Cancer Immunotherapy Drug Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Non-Specific Cancer Immunotherapy Drug Capacity of Key Manufacturers in 2015
Figure China Non-Specific Cancer Immunotherapy Drug Capacity of Key Manufacturers in 2016
Table China Non-Specific Cancer Immunotherapy Drug Production of Key Manufacturers (2015 and 2016)
Table China Non-Specific Cancer Immunotherapy Drug Production Share by Manufacturers (2015 and 2016)
Figure 2015 Non-Specific Cancer Immunotherapy Drug Production Share by Manufacturers
Figure 2016 Non-Specific Cancer Immunotherapy Drug Production Share by Manufacturers
Table China Non-Specific Cancer Immunotherapy Drug Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Non-Specific Cancer Immunotherapy Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Non-Specific Cancer Immunotherapy Drug Revenue Share by Manufacturers
Table 2016 China Non-Specific Cancer Immunotherapy Drug Revenue Share by Manufacturers
Table China Market Non-Specific Cancer Immunotherapy Drug Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Non-Specific Cancer Immunotherapy Drug Average Price of Key Manufacturers in 2015
Table Manufacturers Non-Specific Cancer Immunotherapy Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Non-Specific Cancer Immunotherapy Drug Product Type
Figure Non-Specific Cancer Immunotherapy Drug Market Share of Top 3 Manufacturers
Figure Non-Specific Cancer Immunotherapy Drug Market Share of Top 5 Manufacturers
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Non-Specific Cancer Immunotherapy Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Amgen Non-Specific Cancer Immunotherapy Drug Market Share (2011-2016)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Non-Specific Cancer Immunotherapy Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Non-Specific Cancer Immunotherapy Drug Market Share (2011-2016)
Table Bristol Myers Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol Myers Squibb Non-Specific Cancer Immunotherapy Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bristol Myers Squibb Non-Specific Cancer Immunotherapy Drug Market Share (2011-2016)
Table Dendreon (Valeant) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Dendreon (Valeant) Non-Specific Cancer Immunotherapy Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Dendreon (Valeant) Non-Specific Cancer Immunotherapy Drug Market Share (2011-2016)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Non-Specific Cancer Immunotherapy Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Non-Specific Cancer Immunotherapy Drug Market Share (2011-2016)
Table Seattle Genetics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Seattle Genetics Non-Specific Cancer Immunotherapy Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Seattle Genetics Non-Specific Cancer Immunotherapy Drug Market Share (2011-2016)
Figure China Non-Specific Cancer Immunotherapy Drug Capacity, Production and Growth (2011-2016)
Figure China Non-Specific Cancer Immunotherapy Drug Revenue (Million USD) and Growth (2011-2016)
Table China Non-Specific Cancer Immunotherapy Drug Production, Consumption, Export and Import (2011-2016)
Table China Non-Specific Cancer Immunotherapy Drug Production by Type (2011-2016)
Table China Non-Specific Cancer Immunotherapy Drug Production Share by Type (2011-2016)
Figure Production Market Share of Non-Specific Cancer Immunotherapy Drug by Type (2011-2016)
Figure 2015 Production Market Share of Non-Specific Cancer Immunotherapy Drug by Type
Table China Non-Specific Cancer Immunotherapy Drug Revenue by Type (2011-2016)
Table China Non-Specific Cancer Immunotherapy Drug Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Non-Specific Cancer Immunotherapy Drug by Type (2011-2016)
Figure 2015 Revenue Market Share of Non-Specific Cancer Immunotherapy Drug by Type
Table China Non-Specific Cancer Immunotherapy Drug Price by Type (2011-2016)
Figure China Non-Specific Cancer Immunotherapy Drug Production Growth by Type (2011-2016)
Table China Non-Specific Cancer Immunotherapy Drug Consumption by Application (2011-2016)
Table China Non-Specific Cancer Immunotherapy Drug Consumption Market Share by Application (2011-2016)
Figure China Non-Specific Cancer Immunotherapy Drug Consumption Market Share by Application in 2015
Table China Non-Specific Cancer Immunotherapy Drug Consumption Growth Rate by Application (2011-2016)
Figure China Non-Specific Cancer Immunotherapy Drug Consumption Growth Rate by Application (2011-2016)
Table China Non-Specific Cancer Immunotherapy Drug Production by Regions (Provinces)(2011-2016)
Table China Non-Specific Cancer Immunotherapy Drug Production Market Share by Regions (Provinces)(2011-2016)
Table China Non-Specific Cancer Immunotherapy Drug Production Value by Regions (Provinces)(2011-2016)
Table China Non-Specific Cancer Immunotherapy Drug Production Value Market Share by Regions (Provinces)(2011-2016)
Table China Non-Specific Cancer Immunotherapy Drug Sales Price by Regions (Provinces)(2011-2016)
Table China Non-Specific Cancer Immunotherapy Drug Consumption by Regions (Provinces)(2011-2016)
Table China Non-Specific Cancer Immunotherapy Drug Consumption Market Share by Regions (Provinces)(2011-2016)
Table China Non-Specific Cancer Immunotherapy Drug Production, Consumption, Export and Import (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Non-Specific Cancer Immunotherapy Drug
Figure Manufacturing Process Analysis of Non-Specific Cancer Immunotherapy Drug
Figure Non-Specific Cancer Immunotherapy Drug Industrial Chain Analysis
Table Raw Materials Sources of Non-Specific Cancer Immunotherapy Drug Major Manufacturers in 2015
Table Major Buyers of Non-Specific Cancer Immunotherapy Drug
Table Distributors/Traders List
Figure China Non-Specific Cancer Immunotherapy Drug Capacity, Production and Growth Rate Forecast (2016-2021)
Figure China Non-Specific Cancer Immunotherapy Drug Revenue and Growth Rate Forecast (2016-2021)
Table China Non-Specific Cancer Immunotherapy Drug Production, Import, Export and Consumption Forecast (2016-2021)
Table China Non-Specific Cancer Immunotherapy Drug Production Forecast by Type (2016-2021)
Table China Non-Specific Cancer Immunotherapy Drug Consumption Forecast by Application (2016-2021)
Table China Non-Specific Cancer Immunotherapy Drug Production Forecast by Regions (Provinces)(2016-2021)
Table China Non-Specific Cancer Immunotherapy Drug Consumption Forecast by Regions (Provinces)(2016-2021)
Table China Non-Specific Cancer Immunotherapy Drug Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)